Interferon-γ(IFN-γ) production can be improved by enhancing the biosynthesis of immune-stimulating molecules and metabolites, and oral bifidobacterium enhances tumor suppression to the same extent as specific antibody PD-L1 immunotherapy. This evidence concerns the gene CD274 and neoplasm.